Peter Blume‐Jensen

6.6k citations
25 papers · 5.0k indexed · 1 hit paper · h-index 18

Impact in

Papers in

    • PI3K/AKT/mTOR signaling in cancer 11
    • Protein Kinase Regulation and GTPase Signaling 8
    • Fibroblast Growth Factor Research 2
    • Molecular Biology Techniques and Applications 2
    • Protein Degradation and Inhibitors 2

Peter Blume‐Jensen

25 papers receiving 4.9k citations

Hit Papers

Oncogenic kinase signalling 2001 · 2.9k citations
2.9k200120262009201750010001.5k2.0k2.5k

Peers

Peter Blume‐Jensen
Comparison fields: 5 of 117
  • Immunology and Allergy 332
  • Molecular Biology 3.3k
  • Oncology 1.3k
  • Hematology 488
  • Immunology 840
Replace Henrik Daub with:
Henrik Daub Germany
Maria Rita Nicotra Italy
Laura K. Shawver United States
Dominic Fan United States
John F. Lyons United States
Jonathan A. Pachter United States
Yosef Yarden Israel
Lori S. Friedman United States
Jeffrey A. Toretsky United States
William J. Gullick United Kingdom
Peter Blume‐Jensen relative to Henrik Daub Germany Henrik Daub's profile →
Citations per field
00.5×1.5×
Henrik Daub · 1×
Citations per year

Countries citing papers authored by Peter Blume‐Jensen

Since Specialization
Citations

This map shows the geographic impact of Peter Blume‐Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Blume‐Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Blume‐Jensen more than expected).

Fields of papers citing papers by Peter Blume‐Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Blume‐Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Blume‐Jensen. The network helps show where Peter Blume‐Jensen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Blume‐Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Blume‐Jensen Line = papers co-authored together Peter Blume‐Jensen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202221
2 2014104
3 201449
4 201123
5 2010134
6 201041
7
Increased proliferation of interstitial cells of Cajal due to altered desensitization of c-Kit
20061
8
RNA interference for the identification of disease-associated genes.
20048
9 200314
10 20039
11
Oncogenic kinase signalling
Hit paper breakdown →
20012888
12 2000271
13 1999175
14 1998307
15 199741
16 199583
17 199486
18 199399
19 199229
20 1991278

About Peter Blume‐Jensen

Peter Blume‐Jensen is a scholar working on Immunology and Allergy, Molecular Biology, Oncology, Immunology and Genetics, having authored 25 papers that have together received 5.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Mast cells and histamine (4 papers), HER2/EGFR in Cancer Research (3 papers), Prostate Cancer Treatment and Research (3 papers), Fibroblast Growth Factor Research (2 papers), Molecular Biology Techniques and Applications (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Immunology and Allergy (332 citations), Molecular Biology (3.3k citations), Oncology (1.3k citations), Hematology (488 citations) and Immunology (840 citations). Peter Blume‐Jensen has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Tony Hunter, Guoqiang Jiang, Ralf Janknecht, Lars Rönnstrand, Lena Claesson‐Welsh, Zhimin Lu, Carl‐Henrik Heldin, C H Heldin, Agneta Siegbahn and Bengt Westermark. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal, Neurogastroenterology & Motility, British Journal of Cancer and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026